Systemic Release of Tumor Necrosis Factor Alpha in Human Allogeneic Bone Marrow Transplantation: Clinical Risk Factors, Prognostic Significance, and Therapeutic Approaches
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Low Incidence of Transplant-Related Complications in Patients with Chronic Release of Tumor Necrosis Factor-Alpha before Admission to Bone Marrow Transplantation: A Clinical Correlate of Cytokine Desensitization?Pathobiology, 1991
- Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo applicationCytokine, 1990
- Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]Blood, 1990
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Graft‐versus‐Host Disease in Dog and Man: The Seattle ExperienceImmunological Reviews, 1985